Literature DB >> 26379408

CTLA-4 and MDR1 polymorphisms increase the risk for ulcerative colitis: A meta-analysis.

Jia-Jun Zhao1, Di Wang1, Hui Yao1, Da-Wei Sun1, Hong-Yu Li1.   

Abstract

AIM: To evaluate the correlations between cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) and multi-drug resistance 1 (MDR1) genes polymorphisms with ulcerative colitis (UC) risk.
METHODS: PubMed, EMBASE, Web of Science, Cochrane Library, CBM databases, Springerlink, Wiley, EBSCO, Ovid, Wanfang database, VIP database, China National Knowledge Infrastructure, and Weipu Journal databases were exhaustively searched using combinations of keywords relating to CTLA-4, MDR1 and UC. The published studies were filtered using our stringent inclusion and exclusion criteria, the quality assessment for each eligible study was conducted using Critical Appraisal Skill Program and the resultant high-quality data from final selected studies were analyzed using Comprehensive Meta-analysis 2.0 (CMA 2.0) software. The correlations between SNPs of CTLA-4 gene, MDR1 gene and the risk of UC were evaluated by OR at 95%CI. Z test was carried out to evaluate the significance of overall effect values. Cochran's Q-statistic and I(2) tests were applied to quantify heterogeneity among studies. Funnel plots, classic fail-safe N and Egger's linear regression test were inspected for indication of publication bias.
RESULTS: A total of 107 studies were initially retrieved and 12 studies were eventually selected for meta-analysis. These 12 case-control studies involved 1860 UC patients and 2663 healthy controls. Our major result revealed that single nucleotide polymorphisms (SNPs) of CTLA-4 gene rs3087243 G > A and rs231775 G > A may increase the risk of UC (rs3087243 G > A: allele model: OR = 1.365, 95%CI: 1.023-1.822, P = 0.035; dominant model: OR = 1.569, 95%CI: 1.269-1.940, P < 0.001; rs231775 G > A: allele model: OR = 1.583, 95%CI: = 1.306-1.918, P < 0.001; dominant model: OR = 1.805, 95%CI: 1.393-2.340, P < 0.001). In addition, based on our result, SNPs of MDR1 gene rs1045642 C > T might also confer a significant increases for the risk of UC (allele model: OR = 1.389, 95%CI: 1.214-1.590, P < 0.001; dominant model: OR = 1.518, 95%CI: 1.222-1.886, P < 0.001).
CONCLUSION: CTLA-4 gene rs3087243 G > A and rs231775 G > A, and MDR1 gene rs1045642 C > T might confer an increase for UC risk.

Entities:  

Keywords:  Cytotoxic T lymphocyte-associated antigen-4; Meta-analysis; Multi-drug resistance 1; Polymorphism; Ulcerative colitis; rs1045642 C > T; rs231775 G > A; rs3087243 G > A

Mesh:

Substances:

Year:  2015        PMID: 26379408      PMCID: PMC4566373          DOI: 10.3748/wjg.v21.i34.10025

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  43 in total

1.  Heterogeneity testing in meta-analysis of genome searches.

Authors:  Elias Zintzaras; John P A Ioannidis
Journal:  Genet Epidemiol       Date:  2005-02       Impact factor: 2.135

2.  ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach.

Authors:  G-T Ho; N Soranzo; E R Nimmo; A Tenesa; D B Goldstein; J Satsangi
Journal:  Hum Mol Genet       Date:  2006-01-24       Impact factor: 6.150

3.  Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee.

Authors:  Asher Kornbluth; David B Sachar
Journal:  Am J Gastroenterol       Date:  2010-01-12       Impact factor: 10.864

4.  Testing overall and moderator effects in random effects meta-regression.

Authors:  Hilde M Huizenga; Ingmar Visser; Conor V Dolan
Journal:  Br J Math Stat Psychol       Date:  2011-02       Impact factor: 3.380

Review 5.  Is there evidence to claim or deny association between variants of the multidrug resistance gene (MDR1 or ABCB1) and inflammatory bowel disease?

Authors:  Elias Zintzaras
Journal:  Inflamm Bowel Dis       Date:  2011-09-01       Impact factor: 5.325

6.  Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.

Authors:  Walter Reinisch; William J Sandborn; Daniel W Hommes; Geert D'Haens; Stephen Hanauer; Stefan Schreiber; Remo Panaccione; Richard N Fedorak; Mary Beth Tighe; Bidan Huang; Wendy Kampman; Andreas Lazar; Roopal Thakkar
Journal:  Gut       Date:  2011-01-05       Impact factor: 23.059

7.  Association of polymorphic alleles of CTLA4 with inflammatory bowel disease in the Japanese.

Authors:  Haruhisa Machida; Kazuhiro Tsukamoto; Chun-Yang Wen; Yukiko Narumi; Saburou Shikuwa; Hajime Isomoto; Fuminao Takeshima; Yohei Mizuta; Norio Niikawa; Ikuo Murata; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

8.  Characterization of the human MDR1 gene.

Authors:  Miklos Bodor; Edward J Kelly; Rodney J Ho
Journal:  AAPS J       Date:  2005-02-16       Impact factor: 4.009

9.  MDR1 C3435T polymorphism is predictive of later onset of ulcerative colitis in Japanese.

Authors:  Tatsuya Osuga; Toshiyuki Sakaeda; Tsutomu Nakamura; Toshio Yamada; Tatsuya Koyama; Takao Tamura; Nobuo Aoyama; Noboru Okamura; Masato Kasuga; Katsuhiko Okumura
Journal:  Biol Pharm Bull       Date:  2006-02       Impact factor: 2.233

10.  Balance capabilities after lateral ankle trauma and intervention: a meta-analysis.

Authors:  Erik A Wikstrom; Sagar Naik; Neha Lodha; James H Cauraugh
Journal:  Med Sci Sports Exerc       Date:  2009-06       Impact factor: 5.411

View more
  8 in total

1.  Genetic polymorphism patterns suggest a genetic driven inflammatory response as pathogenesis in appendicitis.

Authors:  Jan Dimberg; Marie Rubér; Marita Skarstedt; Manne Andersson; Roland E Andersson
Journal:  Int J Colorectal Dis       Date:  2019-12-16       Impact factor: 2.571

Review 2.  Glucocorticoid receptor modulates dendritic cell function in ulcerative colitis.

Authors:  Xinxin Yang; Jingshu Geng; Hongxue Meng
Journal:  Histol Histopathol       Date:  2020-07-24       Impact factor: 2.303

3.  Constitutive androstane receptor regulates the intestinal mucosal response to injury.

Authors:  Grace M Hudson; Kyle L Flannigan; Sarah L Erickson; Fernando A Vicentini; Alexandra Zamponi; Christina L Hirota; Laurie Alston; Christophe Altier; Subrata Ghosh; Kevin P Rioux; Sridhar Mani; Thomas K Chang; Simon A Hirota
Journal:  Br J Pharmacol       Date:  2017-04-19       Impact factor: 8.739

4.  Contribution of the Skin-Gut Axis to Immune-Related Adverse Events with Multi-System Involvement.

Authors:  Alyce M Kuo; Lukas Kraehenbuehl; Stephanie King; Donald Y M Leung; Elena Goleva; Andrea P Moy; Mario E Lacouture; Neil J Shah; David M Faleck
Journal:  Cancers (Basel)       Date:  2022-06-17       Impact factor: 6.575

5.  P-glycoprotein multidrug transporter in inflammatory bowel diseases: More questions than answers.

Authors:  Elke Cario
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

6.  Association of Cytotoxic T Lymphocyte Antigen-4 Gene Polymorphisms with Psoriasis Vulgaris: A Case-Control Study in Turkish Population.

Authors:  Hatice Gül Dursun; Hüseyin Osman Yılmaz; Recep Dursun; Sevsen Kulaksızoğlu
Journal:  J Immunol Res       Date:  2018-04-23       Impact factor: 4.818

7.  Non-HLA Genetic Factors and Their Influence on Heart Transplant Outcomes: A Systematic Review.

Authors:  Jessica van Setten; Evangeline G Warmerdam; Olivier Q Groot; Nicolaas de Jonge; Brendan Keating; Folkert W Asselbergs
Journal:  Transplant Direct       Date:  2019-01-21

8.  Association of Inherited Genotype and Severity of Clinical Presentation in Subjects with Verified Pas III Disorder.

Authors:  Vanja Karlovic Beslic; Azra Burekovic; Zahida Drace; Zelija Velija-Asimi; Amela Dizdarevic-Bostandzic
Journal:  Mater Sociomed       Date:  2022-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.